Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (35,578,067)	$ (32,938,065)	$ (14,380,083)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	15,800,554	14,979,398	6,590,960
Amortization of debt issuance costs	1,278,578	1,499,924	1,097,941
Stock based compensation expense related to issuance of restricted stock	38,094	25,814	22,595
Accretion of preferred equity costs		189,920
Unrealized derivative gain (loss)	(482,632)	90,825
Derivative fair value adjustment	1,770,963	2,553,422
Unrealized foreign currency adjustment	6,513,187	(528,949)	1,142,611
Changes in operating assets and liabilities:
Other assets, net	530,680	(2,785,513)	(1,035,249)
Purchase of interest rate derivative	(2,913,815)	(3,279,000)
Purchase of foreign exchange derivative		(1,442,000)
Accounts payable and accrued liabilities	(599,126)	5,138,182	1,712,665
Due to affiliates	8,127,545	3,869,115	233,322
Net cash used in operating activities	(5,514,039)	(12,626,927)	(4,615,238)
Cash flows from investing activities:
Purchase of real estate facilities		(252,273,853)	(188,181,815)
Additions to real estate facilities	(10,388,088)	(8,078,768)	(1,453,968)
Deposits on acquisitions of real estate facilities and investments in unconsolidated real estate ventures		(148,220)	(548,970)
Refund of deposits on acquisitions of real estate facilities	481,866
Investment in company owned life insurance	(902,063)	(886,460)
Investments in unconsolidated real estate ventures	(17,702,419)	(7,171,769)	(499,202)
Return of capital on investments in unconsolidated real estate ventures	15,988,299
Net cash used in investing activities	(12,522,405)	(268,559,070)	(190,683,955)
Cash flows from financing activities:
Proceeds from issuance of secured debt	8,000,000	179,324,261	140,603,502
Repayment of secured debt	(4,764,241)	(50,000,000)	(30,608,851)
Scheduled principal payments of secured debt	(4,160,385)	(862,320)	(123,981)
Prepaid debt issuance costs		(42,000)	(58,000)
Debt issuance costs	(480,950)	(1,666,788)	(1,481,549)
Gross proceeds from issuance of common stock	37,371,916	37,910,737	103,913,984
Offering costs	(3,634,282)	(4,387,423)	(9,226,517)
Proceeds from issuance of preferred equity in our Operating Partnership		15,000,000
Redemption of preferred equity in our Operating Partnership		(15,000,000)
Preferred equity in our Operating Partnership issuance costs		(189,920)
Gross proceeds from issuance of preferred stock		150,000,000
Preferred stock issuance costs		(1,400,277)
Proceeds from issuance of Series C Units	1,220,331	3,197,083
Redemption of common stock	(1,860,904)	(419,094)
Distributions paid to common stockholders	(7,626,356)	(6,160,627)	(3,667,288)
Distributions paid to noncontrolling interest in our Operating Partnership	(341,104)	(341,025)	(313,722)
Distributions paid to preferred stockholders	(12,530,766)	(5,218,750)
Distributions paid to preferred unitholders in our Operating Partnership		(271,250)
Net cash provided by financing activities	11,193,259	299,472,607	199,037,578
Impact of foreign exchange rate changes on cash and restricted cash	(1,299,322)	(370,083)	(527,600)
Net change in cash, cash equivalents and restricted cash	(8,142,507)	17,916,527	3,210,785
Cash, cash equivalents and restricted cash, beginning of year	25,708,071	7,791,544	4,580,759
Cash, cash equivalents and restricted cash, end of year	17,565,564	25,708,071	7,791,544
Supplemental disclosures and non-cash transactions:
Cash paid for interest, net of amounts capitalized	17,208,371	18,819,476	3,345,009
Distribution of common stock		6,586,579
Offering costs included in accounts payable and accrued liabilities	588,163	661,400	1,107,528
Interest rate swap contract in other assets	467,719	145,375	126,864
Interest rate swap contracts in accounts payable and accrued liabilities	368,600	170,708
Foreign currency hedge contract in other assets	1,281,151
Foreign currency translation adjustment	4,808,321	(57,174)	191,438
Deposits applied to investments in unconsolidated real estate ventures	328,545
Deposits on acquisition of real estate facilities in due to affiliates		333,495	751,460
Debt issuance costs in accounts payable and accrued liabilities			26,940
Proceeds from issuance of common stock in accounts payable and accrued liabilities			(211,000)
Issuance of shares pursuant to distribution reinvestment plan	5,736,254	4,391,918	2,544,690
Distributions payable to common and preferred stockholders	4,380,620	4,174,068	798,955
Distributions payable to noncontrolling interests in our Operating Partnership	28,885	28,964	28,964
Real estate and construction in process in accounts payable and accrued liabilities	1,658,865	913,229	$ 553,438
Redemption of common stock in accounts payable and accrued liabilities	$ 442,933	118,691
Unrealized derivative adjustment		576,497
Deposits applied to acquisition of real estate		$ 1,076,020